Elicio Therapeutics, Inc. Fair Value Adjustment of Warrants
Elicio Therapeutics, Inc. (ELTX) reported Fair Value Adjustment of Warrants of -$2.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-13
- Elicio Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was -$2.48M, a 389.06% decline year-over-year.
- Elicio Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $984.00K, a 94.08% increase year-over-year.
- Elicio Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$1.26M, a 307.91% decline year-over-year.
- Elicio Therapeutics, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $1.81M, a 67.76% decline year-over-year.
- Elicio Therapeutics, Inc. fair value adjustment of warrants for fiscal 2025 was $1.92M, a 50.72% decline from fiscal 2024.
- Elicio Therapeutics, Inc. fair value adjustment of warrants for fiscal 2024 was $3.89M, a 194200.00% increase from fiscal 2023.
- Elicio Therapeutics, Inc. fair value adjustment of warrants for fiscal 2023 was $2.00K.
- Elicio Therapeutics, Inc. fair value adjustment of warrants for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 6 month as first filed | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.48M 10-Q · filed 2026-08-13 | -$1.50M 10-Q · filed 2026-08-13 | -$2.76M derived: sum of 3 quarters · filed 2026-08-13 | -$950.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $984.00K 10-Q · filed 2026-05-11 | -$278.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.53M derived: sum of 3 quarters · filed 2026-05-11 | $2.39M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $549.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.41M derived: sum of 3 quarters · filed 2026-08-13 | $1.92M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $1.81M 10-Q · filed 2025-11-13 | $2.67M derived: sum of 2 quarters · filed 2026-08-13 | $3.18M 10-Q · filed 2025-11-13 | $3.78M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $859.00K 10-Q · filed 2026-08-13 | $1.37M 10-Q · filed 2026-08-13 | $1.97M derived: sum of 3 quarters · filed 2026-08-13 | $7.59M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $507.00K 10-Q · filed 2026-05-11 | $1.11M derived: sum of 2 quarters · filed 2026-05-11 | $6.73M derived: sum of 3 quarters · filed 2026-05-11 | $3.12M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $607.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $6.22M derived: sum of 2 quarters · filed 2026-03-12 | $2.61M derived: sum of 3 quarters · filed 2026-03-12 | $3.89M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $5.62M 10-Q · filed 2025-11-13 | $2.00M derived: sum of 2 quarters · filed 2025-11-13 | $3.28M 10-Q · filed 2025-11-13 | $3.26M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$3.62M 10-Q · filed 2025-08-07 | -$2.34M 10-Q · filed 2025-08-07 | -$2.35M derived: sum of 3 quarters · filed 2025-08-07 | -$2.36M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $1.28M 10-Q · filed 2025-05-13 | $1.26M derived: sum of 2 quarters · filed 2025-05-13 | $1.26M derived: sum of 3 quarters · filed 2025-05-13 | $1.28M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$21.00K derived: sum of 2 quarters · filed 2025-03-31 | $2.00K derived: sum of 3 quarters · filed 2025-03-31 | $2.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$6.00K 10-Q · filed 2024-11-13 | $17.00K derived: sum of 2 quarters · filed 2024-11-13 | $17.00K 10-Q · filed 2024-11-13 | $17.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $23.00K 10-Q · filed 2024-08-13 | $23.00K 10-Q · filed 2024-08-13 | $23.00K derived: sum of 3 quarters · filed 2024-08-13 | $23.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | -$10.00K 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $0.00 derived: sum of 3 quarters · filed 2024-05-15 | $0.00 derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $0.00 derived: sum of 2 quarters · filed 2024-03-29 | $0.00 derived: sum of 3 quarters · filed 2024-03-29 | $0.00 10-K · filed 2024-03-29 | -$95.00K 10-K · filed 2023-03-17 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | -$9.00K 10-Q · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | -$90.00K 10-Q · filed 2022-11-14 | -$311.00K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 | -$42.00K 10-Q · filed 2022-08-15 | $0.00 10-Q · filed 2023-08-14 | -$81.00K 10-Q · filed 2022-08-15 | -$311.00K derived: sum of 3 quarters · filed 2023-08-14 | -$439.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$39.00K 10-Q · filed 2023-05-10 | -$311.00K derived: sum of 2 quarters · filed 2023-05-10 | -$439.00K derived: sum of 3 quarters · filed 2023-05-10 | -$639.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | -$272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | -$400.00K derived: sum of 2 quarters · filed 2023-03-17 | -$600.00K derived: sum of 3 quarters · filed 2023-03-17 | $2.92M 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | -$128.00K 10-Q · filed 2022-11-14 | -$328.00K derived: sum of 2 quarters · filed 2022-11-14 | $3.19M 10-Q · filed 2022-11-14 | $6.84M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$200.00K 10-Q · filed 2022-08-15 | $3.32M 10-Q · filed 2022-08-15 | $6.97M derived: sum of 3 quarters · filed 2022-08-15 | $7.48M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $3.52M 10-Q · filed 2022-05-16 | $7.17M derived: sum of 2 quarters · filed 2022-05-16 | $7.68M derived: sum of 3 quarters · filed 2022-05-16 | $8.14M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $3.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $4.16M derived: sum of 2 quarters · filed 2022-03-30 | $4.62M derived: sum of 3 quarters · filed 2022-03-30 | $4.91M 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $513.00K 10-Q · filed 2021-11-12 | $969.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.26M 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $456.00K 10-Q · filed 2021-08-12 | $748.00K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $292.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |